Psoriasis News

Patients with psoriasis treated with higher doses of oral zasocitinib experienced greater improvement than those treated with placebo, according to a phase 2b study.

Healio has compiled June’s most-read news in dermatology.

Makeup not only has cosmetic applications, but medical ones too.

Ilumetri effectively restored the level of well-being of patients with moderate to severe plaque psoriasis to those of the general population, according to interim results released by Almirall.

The FDA has approved the Stelara biosimilar Pyzchiva for psoriatic arthritis, Crohn’s disease and all other indications approved for the reference medicine, according to a press release from Sandoz.

Vtama cream 1% has been approved in Japan for the treatment of adults with psoriasis as well as patients aged 12 years and older with atopic dermatitis, Dermavant Sciences announced in a press release.

Dermatologists should be on the lookout for new forms of a highly contagious fungal infection now being reported in the U.S., according to a press release from NYU Langone Health.

Due to medical advancements, researchers are calling for an update to the U.S. Department of Defense’s policies restricting individuals with psoriasis and atopic dermatitis from joining and remaining in the military, according to a study.

CLEVELAND — Dermatology and rheumatology often work together in the treatment of psoriasis and psoriatic arthritis.

Patients with atherosclerosis and elevated LDL plus autoimmune or inflammatory disease may derive particular CV benefit from PCSK9 inhibition with evolocumab, a speaker reported.